0001513162-20-000174.txt : 20200817 0001513162-20-000174.hdr.sgml : 20200817 20200817163746 ACCESSION NUMBER: 0001513162-20-000174 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200813 FILED AS OF DATE: 20200817 DATE AS OF CHANGE: 20200817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MONAHAN JOHN J CENTRAL INDEX KEY: 0001257825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37492 FILM NUMBER: 201110727 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anixa Biosciences Inc CENTRAL INDEX KEY: 0000715446 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112622630 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250 CITY: SAN JOSE STATE: CA ZIP: 95118 BUSINESS PHONE: 408-708-9808 MAIL ADDRESS: STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250 CITY: SAN JOSE STATE: CA ZIP: 95118 FORMER COMPANY: FORMER CONFORMED NAME: ITUS Corp DATE OF NAME CHANGE: 20140902 FORMER COMPANY: FORMER CONFORMED NAME: COPYTELE INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-08-13 0 0000715446 Anixa Biosciences Inc ANIX 0001257825 MONAHAN JOHN J C/O ANIXA BIOSCIENCES, INC. 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 1 0 0 0 Employee Stock Option (Right to Buy) 2.68 2020-08-13 4 A 0 30000 0 A 2030-08-13 Common Stock 30000 30000 D Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. The options vest and become exercisable in twelve (12) equal monthly installments beginning August 31, 2020. /s/ John J. Monahan 2020-08-17